FI952721A0 - Aine maksa-sappi-sairauksien hoitamiseksi - Google Patents

Aine maksa-sappi-sairauksien hoitamiseksi

Info

Publication number
FI952721A0
FI952721A0 FI952721A FI952721A FI952721A0 FI 952721 A0 FI952721 A0 FI 952721A0 FI 952721 A FI952721 A FI 952721A FI 952721 A FI952721 A FI 952721A FI 952721 A0 FI952721 A0 FI 952721A0
Authority
FI
Finland
Prior art keywords
treatment
liver
agents
gall disease
methyl group
Prior art date
Application number
FI952721A
Other languages
English (en)
Swedish (sv)
Other versions
FI952721A (fi
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of FI952721A0 publication Critical patent/FI952721A0/fi
Publication of FI952721A publication Critical patent/FI952721A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952721A 1994-06-03 1995-06-02 Aine maksa-sappi-sairauksien hoitamiseksi FI952721A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12248794 1994-06-03

Publications (2)

Publication Number Publication Date
FI952721A0 true FI952721A0 (fi) 1995-06-02
FI952721A FI952721A (fi) 1995-12-04

Family

ID=14837070

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952721A FI952721A (fi) 1994-06-03 1995-06-02 Aine maksa-sappi-sairauksien hoitamiseksi

Country Status (14)

Country Link
US (1) US5739161A (fi)
EP (1) EP0690049B1 (fi)
KR (1) KR100260573B1 (fi)
CN (1) CN1076605C (fi)
AT (1) ATE182884T1 (fi)
AU (1) AU690241B2 (fi)
CA (1) CA2150287C (fi)
DE (1) DE69511181T2 (fi)
DK (1) DK0690049T3 (fi)
ES (1) ES2137456T3 (fi)
FI (1) FI952721A (fi)
GR (1) GR3031066T3 (fi)
NO (1) NO308993B1 (fi)
NZ (1) NZ272234A (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
DE60010913T2 (de) 1999-10-15 2005-06-09 Sucampo Ag Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung
AU2001239551B8 (en) 2000-03-24 2005-11-24 Sucampo Ag Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
WO2001076593A2 (en) 2000-04-06 2001-10-18 Sucampo Ag Bile secretion promoting composition a 15-keto prostaglandin
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
WO2003030912A1 (en) 2001-08-31 2003-04-17 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
DK1562604T3 (da) * 2002-10-23 2012-04-02 Sucampo Ag Prostaglandinforbindelser til behandling af fedme
JP4889219B2 (ja) 2002-12-27 2012-03-07 スキャンポ・アーゲー 腹部不快感の処置のためのプロスタグランジン誘導体
JP5294559B2 (ja) * 2003-07-03 2013-09-18 スキャンポ・アーゲー クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
EP2404606A1 (en) 2003-08-21 2012-01-11 Sucampo AG Ophthalmic compositions comprising a prostaglandin and a viscosity agent
JP4690814B2 (ja) * 2004-08-02 2011-06-01 株式会社アールテック・ウエノ プロスタグランジン誘導体の製造法
JP5147404B2 (ja) * 2005-01-27 2013-02-20 スキャンポ・アーゲー 中枢神経系障害の処置のための方法および組成物
TWI432201B (zh) * 2005-03-04 2014-04-01 Sucampo Ag 11-去氧基-***素化合物用於治療週邊血管疾病之用途
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
JP5711442B2 (ja) * 2005-04-12 2015-04-30 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用
US8026393B2 (en) 2006-01-24 2011-09-27 Sucampo Ag Soft-gelatin capsule formulation
MX2008009652A (es) 2006-01-24 2008-11-06 R Tech Ueno Ltd Composicion farmaceutica que comprende un compuesto biciclico y metodo para estabilizar el compuesto biciclico.
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
CA2856675C (en) * 2006-02-07 2016-04-26 R-Tech Ueno, Ltd. Prostaglandin derivatives
AR059636A1 (es) * 2006-02-28 2008-04-16 Sucampo Ag Metodo y composicion para tratar la enfermedad pulmonar obstructiva cronica
KR101382922B1 (ko) 2006-03-13 2014-04-08 가부시키가이샤 아루떼꾸 우에노 수성 조성물
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US8889735B2 (en) 2011-04-07 2014-11-18 Sucampo Ag Method for treating asthenopia
AU2012246999A1 (en) * 2011-04-19 2013-10-17 Sucampo Ag Method for modulating cytokine activity
JP2014522805A (ja) * 2011-07-01 2014-09-08 株式会社アールテック・ウエノ 脂肪酸誘導体の製造法
CN102875586A (zh) * 2011-07-11 2013-01-16 上海天伟生物制药有限公司 一种利马前列素关键中间体的制备方法
SG10201606442QA (en) 2011-08-05 2016-09-29 Sucampo Ag Method for treating schizophrenia
CN103058907B (zh) * 2011-10-21 2016-05-11 武汉启瑞药业有限公司 鲁比前列酮或其中间体的制备方法
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative
US10428566B2 (en) * 2017-04-17 2019-10-01 James G. Arendts Flexible unitary sandwich-like panel overhead door

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306078A (en) * 1979-12-03 1981-12-15 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4374856A (en) 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
JPS58164512A (ja) 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS58203911A (ja) 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS62129218A (ja) 1985-12-02 1987-06-11 Teijin Ltd チアプロスタグランジン類を活性成分として含有する肝疾患治療剤
JPH0688966B2 (ja) 1987-01-28 1994-11-09 株式会社アールテック・ウエノ プロスタグランジンｅ類およびそれを含む抗潰瘍剤
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
JPH0681728B2 (ja) 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
EP0310305B1 (en) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
JP2579193B2 (ja) * 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
DD295522A5 (de) * 1989-07-26 1991-11-07 �����@������������������k�� 5-Alkyl-1,3,4-Thiadiazole, Verfahren zu ihrer Herstellung und Verwendung als Schädlingsbekämpfungsmittel
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Also Published As

Publication number Publication date
CA2150287C (en) 2004-08-10
FI952721A (fi) 1995-12-04
ATE182884T1 (de) 1999-08-15
NO952214D0 (no) 1995-06-02
NZ272234A (en) 1996-02-27
DK0690049T3 (da) 2000-03-06
NO952214L (no) 1995-12-04
US5739161A (en) 1998-04-14
DE69511181T2 (de) 1999-12-02
ES2137456T3 (es) 1999-12-16
KR100260573B1 (ko) 2000-07-01
CN1126591A (zh) 1996-07-17
KR960000230A (ko) 1996-01-25
DE69511181D1 (de) 1999-09-09
EP0690049B1 (en) 1999-08-04
CN1076605C (zh) 2001-12-26
NO308993B1 (no) 2000-11-27
GR3031066T3 (en) 1999-12-31
AU2041295A (en) 1995-12-14
EP0690049A3 (en) 1997-03-26
AU690241B2 (en) 1998-04-23
CA2150287A1 (en) 1995-12-04
EP0690049A2 (en) 1996-01-03

Similar Documents

Publication Publication Date Title
FI952721A0 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
DK0626375T3 (da) Octacyclodepsipeptider med endoparasiticid virkning
DE69324859T2 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
ES2059296T1 (es) Inhibidores de proteasa retroviral.
EE9700275A (et) 1,3-propaandiooli derivaadid bioaktiivsete ühenditena
MA23603A1 (fr) Derives d'oxalylamino-benzafuranne et benzothienyle.
DK0973920T3 (da) Et oleosin 5'-regulerende område til modifikationen af plantefrölipidsammensætning
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
MX9302931A (es) Nuevas 4-aza-5&-colestan-onas 7b-substituidas como inhibidores de 5&-reductasa.
FR2753447B1 (fr) Hydroxyphenyltriazines comme agents stabilisants de matieres organiques
BR9510012A (pt) Processo para a purificação de uma composição de 1,3-propanodiol contendo carbonila
DE69716810T2 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
TR199500895A2 (tr) 2-(2-amino-1,6-dihidro-6-okso-purin-9-il) metoksi-1,3-propandiol türevi.
FI933847A0 (fi) Herbicidkompositioner
ES2146606T3 (es) Metodo para limpiar alfombras.
DE69013787T2 (de) Ammonium-verbindung, diese enthaltende zusammensetzung und desinfektionsverfahren.
NO942983L (no) Farmasöytiske sammensetninger
DE59501060D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
EA199900888A1 (ru) Противоревматические средства
DE59509651D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
DE59208442D1 (de) Beschichtungsmittel
FI960558A (fi) Aksiaalisuunnassa liikkuva akselijärjestely
ATE262527T1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate